Finding optimal multi-drug combinations for pancreatic cancer remains a complex task. Here, authors across three different groups apply machine learning approaches to predict synergy across 1.6 million combinations of drugs for pancreatic cancer, 307 of which are validated experimentally.
- Mohsen Pourmousa
- Sankalp Jain
- Alexey V. Zakharov
